|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.37 USD | -12.60% |
|
-36.32% | -64.58% |
Applied DNA Sciences, Inc. reported earnings results for the fourth quarter ended September 30, 2023. For the fourth quarter, the company reported revenue was USD 0.779736 million compared to USD 3.56 million a year ago. Net loss was USD 3.59 million compared to USD 0.663219 million a year ago.
Basic loss per share from continuing operations was USD 5.2 compared to USD 1.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -64.58% | 3.77M | |
| +0.89% | 12.8B | |
| -10.29% | 7.61B | |
| +1.78% | 5.41B | |
| -1.16% | 4.51B | |
| +5.74% | 4.49B | |
| -50.70% | 3.29B | |
| +12.21% | 2.73B | |
| -16.13% | 2.02B | |
| -11.50% | 1.73B |
APPLIED DNA SCIENCES, INC. 
